Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Zoloft)

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Strong evidence points to a link between poor impulse control (impulsivity) and violent crime. Impulsivity has been shown to be associated with reduced levels of the neurotransmitter serotonin. In studies of impulsive individuals, selective serotonin reuptake inhibitors (SSRIs) have reduced impulsive aggression but there has been no systematic study of the benefits of SSRIs for violent offenders at risk of reoffending. This research will investigate whether SSRIs can reduce repeat violent offending.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2017

Funding Scheme: Partnerships

Funding Amount: $1,337,659.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Other biomedical and clinical sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Antidepressant | Behaviour | Prison population | Randomized controlled trial | mental health